摘要
目的:研究脑星形细胞肿瘤Survivin蛋白表达与其临床、病理和预后的关系。方法:应用免疫组化方法检测65例脑星形细胞肿瘤组织中Survivin蛋白的表达。结果:Survivin仅表达于脑星形细胞肿瘤细胞,而在正常脑组织中无表达。在脑星形细胞肿瘤中Survivin阳性检出率为61.54%(40/65)。Survivin蛋白的表达强度与脑星形细胞肿瘤的病理分级密切相关,在高级别肿瘤中Survivin蛋白的表达强度均高于低级别肿瘤(P<0.05)。结论:随着星形细胞肿瘤分化程度的降低,Survivin蛋白的表达强度均显著增强;Survivin的高表达预示着星形细胞肿瘤患者预后不良,Survivin可成为一个有价值的评估该肿瘤预后的指标。
Objective :To investigate the relationships between the expression of Survivin gene ( at protein levels) and the clinicopathologic parameters in astrocytomas ,and evaluate its significance in predicting the prognosis.Methods:Immunohistochemical method was used to detect Survivin expression in 65 patients with astrocytomas.Results:The expression of Survivin was only found in tumor cells in astrocytomas and there was no expression in normal brain tissues. The positive rate of immunohistochemistry was 61.54%(40/ 65).The expression intensity of Survivin detected by immunohistochemistry had a high correlation with pathological grades of astrocytomas. The expression intensity of Survivin in high-grade tumors was higher than that in low-grade tumors (P〈0.05).Conclusion:The expression intensity of Survivin gene reinforced significantly when the differentiation degree decreased.The high expression of Survivin forestells the bad prognosis of astrocytomas. Survivin can become a valuable evaluation marker for prognosis.
出处
《交通医学》
2006年第6期660-661,664,共3页
Medical Journal of Communications